Tonix Pharm Holdings (TNXP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 190,055 | 125,331 | 131,716 | 98,776 | 28,233 |
| Receivables | 3,481 | 2,320 | 3,312 | 3,683 | 4,013 |
| Inventories | 5,729 | 5,986 | 8,136 | 8,408 | 7,931 |
| TOTAL | $208,071 | $143,535 | $149,573 | $119,002 | $50,543 |
| Non-Current Assets | |||||
| PPE Net | 42,574 | 42,335 | 41,766 | 42,252 | 42,747 |
| Intangibles | 120 | 120 | 120 | 120 | 120 |
| Other Non-Current Assets | 1,675 | 1,369 | 1,411 | 1,516 | 1,579 |
| TOTAL | $44,369 | $43,824 | $43,297 | $43,888 | $44,446 |
| Total Assets | $252,440 | $187,359 | $192,870 | $162,890 | $94,989 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 2,820 | 2,820 |
| Accounts payable and accrued liabilities | 8,540 | 7,783 | 4,193 | 4,546 | 3,935 |
| Accrued Expenses | 12,332 | 11,083 | 7,718 | 10,667 | 8,151 |
| TOTAL | $21,031 | $19,061 | $12,146 | $18,307 | $15,181 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | 4,667 | 5,172 |
| Other Non-Current Liabilities | 266 | 297 | 328 | 358 | 425 |
| TOTAL | $266 | $297 | $328 | $5,025 | $5,597 |
| Total Liabilities | $21,297 | $19,358 | $12,474 | $23,332 | $20,778 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 11,777 | 8,766 | 7,325 | 6,435 | 1,869 |
| Common Shares | 10 | 8 | 7 | 4 | 156 |
| Retained earnings | -807,805 | -775,795 | -747,523 | -730,694 | -708,586 |
| Other shareholders' equity | -274 | -270 | -266 | -255 | -250 |
| TOTAL | $231,143 | $168,001 | $180,396 | $139,558 | $74,211 |
| Total Liabilities And Equity | $252,440 | $187,359 | $192,870 | $162,890 | $94,989 |